Mirion Technologies, Inc.

Mirion Technologies provides radiation protection, measurement, and monitoring products, software, and services across two primary operating segments: Nuclear & Safety and Medical. In the Nuclear & Safety segment, the company delivers systems for reactor instrumentation, radiation monitoring, laboratory analysis, and defense applications. The Medical segment provides cancer care solutions, including radiation therapy quality assurance, nuclear medicine equipment, and occupational dosimetry services. Mirion serves a diverse global client base, including commercial nuclear power plants, research reactors, defense organizations, national laboratories, hospitals, cancer treatment centers, and diagnostic imaging facilities.

Headquartered in Atlanta, Georgia, the company maintains operating facilities across twelve countries, including the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, Japan, and South Korea. Its global presence includes forty-nine sales offices distributed throughout North America, Europe, and Asia, supporting customers across the worldwide nuclear, healthcare, and industrial sectors.

Summary of the business section of Mirion Technologies's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“We have 49 sales offices throughout North America, Europe and Asia, and as of December 31, 2025, our sales and marketing personnel consisted of 324 employees, which represents approximately 10% of our total workforce.”